Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Revenue, Earnings And Profits All Fall At AstraZeneca Plc
Motley Fool
Thu, 08/1/13 - 08:50 am
Tags:
AstraZeneca, earnings
2 Keys to Success for This Diabetes Drug's Second Chance
Motley Fool
Tue, 07/30/13 - 11:35 am
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Forxiga
AstraZeneca, Bristol resubmit NDA for diabetes therapy dapagliflozin
Fierce Biotech
Thu, 07/25/13 - 11:16 am
Tags:
diabetes, Dapagliflozin, Bristol-Myers Squibb, AstraZeneca
[video] Onyx Prepares for Multiple Bids After Amgen Snub
Bloomberg
Tue, 07/23/13 - 11:00 am
Tags:
ONYX Pharmaceuticals, Amgen, M&A, AstraZeneca, Pfizer, Novartis
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, JNJ, SGLT2 inhibitor, Forxiga, Invokana, empagliflozin
AstraZeneca, Pfizer among possible bidders for Onynx, Bloomberg reports
Yahoo/Fly on the Wall
Mon, 07/22/13 - 05:59 pm
Tags:
Pfizer, AstraZeneca, ONYX Pharmaceuticals, M&A
ChinaGate: Glaxo Issues A Mea Culpa And AstraZeneca Is Questioned
Pharmalot
Mon, 07/22/13 - 11:29 am
Tags:
GSK, China, AstraZeneca
The U.S. Antidepressant Market: Old Fashioned Branding Might Save the Day
Motley Fool
Fri, 07/19/13 - 10:31 am
Tags:
antidepressants, AstraZeneca, Eli Lilly, Forest Labs, GSK, Pfizer, Targacept, Cymbalta, Lexapro, Effexor, Pristiq, TC-5214
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Motley Fool
Mon, 07/15/13 - 10:27 am
Tags:
FDA, AstraZeneca, Novartis, Acadia, pimavanserin
After $240 Million AstraZeneca Deal, How Big Will Moderna Get?
Forbes
Fri, 07/12/13 - 10:07 am
Tags:
Moderna, AstraZeneca, MRNA
Common Acid Reflux Drugs May Lead To Heart Disease, New Research Suggests
Forbes
Fri, 07/12/13 - 08:41 am
Tags:
acid reflux, proton pump inhibitors, Nexium, Prevacid, GERD, Prilosec, AstraZeneca, Takeda
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Tags:
Astex, AstraZeneca, Celgene, GSK, JNJ, Novartis, SGI-110, Dacogen
Why AstraZeneca plc's Patent Cliff Presents A Golden Opportunity
Motley Fool
Wed, 07/3/13 - 11:26 am
Tags:
patent cliff, AstraZeneca
Merck: Implications Of Capital Allocation
Seeking Alpha
Wed, 07/3/13 - 11:07 am
Tags:
Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Merck, capital allocation
Vivus's top shareholder proposes former AstraZeneca exec as CEO
Reuters
Tue, 07/2/13 - 09:45 am
Tags:
Vivus, AstraZeneca, Anthony Zook
Bristol-Myers Squibb: Valuation Dependent On Pipeline
Seeking Alpha
Mon, 07/1/13 - 12:31 pm
Tags:
Bristol-Myers Squibb, AstraZeneca
Generic Versions of AstraZeneca’s Pulmicort Respules Enjoined from Launch Pending Appeal in Patent Infringement Case
National Law Review
Sun, 06/30/13 - 11:06 am
Tags:
AstraZeneca, Pulmicort, generics, Patent Infringement, lawsuits
Fish-Oil Pills Lure Drugmakers Even as Benefits Unproven
Bloomberg
Fri, 06/28/13 - 10:23 am
Tags:
Amarin, fish oil, AstraZeneca, GSK
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Tags:
Novo Nordisk, diabetes, Eli Lilly, GLP-1 agonist, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Victoza
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
Tags:
obesity, M&A, Oramed, AstraZeneca, MannKind, Merck, Sanofi, Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.